Hypertension

A new American Heart Association and National Institutes of Health-sponsored study found that use of a polypill reduced cardiovascular risk in a low-income population in Mobile, Alabama.

The number of pregnant women who develop hypertension during the first 20 weeks of pregnancy has spiked in the U.S. since 1979, especially among black women, with advanced maternal age contributing to this upward trend, say researchers writing in Hypertension this month.

Results of the AMBER study, presented at HFSA 2019, found that patiromer can help improve spironolactone use while also reducing the prevalence of hyperkalemia.

Investigators report findings no significant associations between BP control and cardiovascular mortality in patients from differing race/ethnicities with HF, stratified by hypertension treatment.

A recent analysis that included data on 284 patients found that more than 80% of patients with resistant hypertension also had obstructive sleep apnea.

A recent study from investigators at the Rutgers Robert Wood Medical School found that rates of hypertension among pregnant women have spiked between 1970 and 2010.

A study from investigators at Beth Israel Deaconess Medical Center found that more intense hypertensive treatments did not result in added episodes of orthostatic hypotension.

A study from the AHA's Hypertension Scientific Sessions revealed first- and second-year medical students have a 2.4 higher risk of stage 2 hypertension compared to the general public.

A study of human gut bacteria suggests that high blood pressure with depression may be a completely different disease than high blood pressure without depression.

A study from the AHA's 2019 Hypertension Scientific Sessions revealed that hypertension was linked to cognitive decline in older patients, but antihypertensive treatment could mitigate this impact.

A study presented at ESC Congress 2019 revealed childhood BMI, systolic blood pressure, and serum total cholesterol and triglycerides are positively associated with adult CVD.

Updated guidelines for the treatment and diagnosis of chronic coronary diseases were released by the European Society of Cardiology at ESC Congress 2019 in Paris.

The SGLT-2 inhibitor is seeking an additional indication for primary renal outcome prevention in patients with or without type 2 diabetes.

A recent study from Northwestern University found that rates of death caused by cardiometabolic disease in the US are no longer in decline and have been rising since 2011.

A primary investigator-led discussion will tap into how invasive procedures have become more embraced in US cardiology.

A smartwatch and patch product from Biobeat will allow physicians and patients to monitor blood pressure, oxygenation, and heart rates in both inpatient and outpatient settings.

The rates for hypertension diagnosis, treatment and control are still falling short of goals despite awareness programs, researchers report.

Analysis of the Framingham Heart Study found that while quitting smoking lowers a person's CVD risk, that risk may not return to normal for up to 25 years.

In a new cohort study, investigators examine the link between blood pressure and cognitive decline.

Just 2 weeks of therapy could help attenuated autonomic function for geriatric adults.

Professor of medicine at Harvard Medical School discusses how much progress has been made in the fight against cardiovascular disease.